What Are the Symptoms of Advanced Esophageal Cancer?
May 26, 2022
Source: Cainiu Health
Dr. Zhao Haiming
Introduction
Patients with advanced esophageal cancer may develop dysphagia, a symptom that typically progresses gradually. Initially, patients experience difficulty swallowing dry foods; subsequently, even semi-liquid foods such as congee become difficult to swallow; eventually, even water and saliva cannot be swallowed. Patients frequently expectorate mucoid sputum. Due to prolonged inability to eat, they commonly become emaciated, dehydrated, and weak, ultimately progressing to cachexia.
Cancer is a serious illness that profoundly impacts physical health and significantly undermines an individual’s confidence and self-esteem. What symptoms are typically observed in advanced esophageal cancer?
Common Symptoms of Advanced Esophageal Cancer
Patients with advanced esophageal cancer often experience progressive dysphagia (difficulty swallowing). Initially, they may struggle to swallow dry or solid foods; subsequently, even semi-liquid foods such as congee become difficult to ingest; eventually, patients may be unable to swallow water or even their own saliva. They frequently expel thick, mucoid sputum. Due to prolonged inability to eat, patients commonly develop severe weight loss, dehydration, and profound weakness. Ultimately, they may progress to cancer cachexia. If the cancer metastasizes to vital organs—such as the liver or brain—additional symptoms may emerge, including jaundice, ascites, or even coma.
Treatment strategies must be tailored according to the stage of esophageal cancer. In early-stage disease, curative treatment remains possible. For instance, if the tumor arises in the cervical segment, concurrent chemoradiotherapy can achieve long-term disease control. Tumors located in the distal (lower) esophagus may be amenable to surgical resection. Patients with superficial T1-stage disease may be cured via endoscopic resection. For intermediate-stage disease, combination therapies—including targeted therapy, immunotherapy, radiotherapy, and concurrent chemotherapy—are viable options.
Even in advanced (late-stage) esophageal cancer, combined targeted therapy and immunotherapy with chemotherapy offer promising therapeutic potential. Therefore, accurate staging is critical in managing esophageal cancer. Comprehensive systemic evaluation—including imaging and pathological assessment—is essential to determine disease stage, as lymph node metastasis may already be present even in T1-stage patients. With appropriate management, long-term disease control is achievable. Nutritional support must be prioritized alongside active treatment to optimize outcomes and effectively manage the disease. We hope this information has been helpful. Wishing you good health and happiness.
